Last update 26 Oct 2025

Losartan Potassium/Lipoic acid

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Alpha lipoic acid/losartan, Losartan/alpha lipoic acid, Losartan/thioctic acid
+ [2]
Target
AT1R
Action
antagonists
Mechanism
AT1R antagonists(Angiotensin II Receptor Type 1 antagonists)
Therapeutic Areas
Cardiovascular DiseasesEndocrinology and Metabolic DiseaseUrogenital Diseases
Active Indication-
Inactive Indication
Diabetes Mellitus, Type 2HypertensionKidney Diseases
Originator Organization
InVasc Therapeutics, Inc.InVasc Therapeutics, Inc.
Active Organization-
Inactive Organization
InVasc Therapeutics, Inc.InVasc Therapeutics, Inc.
License Organization-
Drug Highest PhasePendingPhase 2
First Approval Date-
Regulation-
Login to view timeline

Structure/Sequence

Molecular FormulaC8H14O2S2
InChIKeyAGBQKNBQESQNJD-SSDOTTSWSA-N
CAS Registry1200-22-2
View All Structures (2)

Related

1
Clinical Trials associated with Losartan Potassium/Lipoic acid
NCT01398423
/ CompletedPhase 2
A 12 Week, Phase II Trial of the Safety, Pharmacokinetics, and Efficacy of INV-144 Compared With Losartan Potassium in Patients With Hypertension and Type 2 Diabetes Mellitus With Nephropathy
100 Clinical Results associated with Losartan Potassium/Lipoic acid
Login to view more data
100 Translational Medicine associated with Losartan Potassium/Lipoic acid
Login to view more data
100 Patents (Medical) associated with Losartan Potassium/Lipoic acid
Login to view more data
100 Deals associated with Losartan Potassium/Lipoic acid
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Diabetes Mellitus, Type 2Phase 2
United States
InVasc Therapeutics, Inc.InVasc Therapeutics, Inc.
01 Jun 2011
HypertensionPhase 2
United States
InVasc Therapeutics, Inc.InVasc Therapeutics, Inc.
01 Jun 2011
Kidney DiseasesPhase 2
United States
InVasc Therapeutics, Inc.InVasc Therapeutics, Inc.
01 Jun 2011
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free